
Seed financing to address ‘liver trap’ in siRNA therapeutic delivery
Undecimal Bio, a platform biotechnology company advancing targeted delivery of siRNA therapeutics, has announced an oversubscribed $18 million seed financing. The company is a spin-out from Eleven Therapeutics and will use the funding to expand DELiveri, its AI-enabled platform for identifying conjugates that can direct RNA… Read More














